Bright Minds Biosciences (DRUG) Long-Term Investments (2021 - 2026)
Powered by 
Analysis
Bright Minds Biosciences (DRUG) Long-Term Investments (2021 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.31 Bn | 131.46 Bn | 2.84 Bn | 5.79 Bn |
| 2 | Regeneron Pharmaceuticals | 85.65 Bn | 77.66 Bn | 3.93 Bn | 9.83 Bn |
| 3 | Argenx Se | 63.46 Bn | 58.27 Bn | 1.37 Bn | -4.00 Mn |
| 4 | Moderna | 57.94 Bn | 52.80 Bn | 52.00 Mn | 1.77 Bn |
| 5 | Revolution Medicines | 44.05 Bn | 44.05 Bn | - | - |
| 6 | BeOne Medicines | 39.96 Bn | 34.86 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.16 Bn | 31.85 Bn | 992.69 Mn | 22.17 Mn |
| 8 | Royalty Pharma | 28.44 Bn | 27.60 Bn | - | 372.10 Mn |
| 9 | Insmed | 27.32 Bn | 26.16 Bn | 358.27 Mn | - |
| 10 | Bright Minds Biosciences | 459.66 Mn | 237.12 Mn | - | 124,704.61 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 124,704.61 |
| Mar 31, 2026 | 125,787.98 |
| Dec 31, 2025 | 123,697.38 |
| Sep 30, 2025 | 62,672.27 |
| Jun 30, 2025 | 62,247.70 |
| Mar 31, 2025 | 60,109.05 |
| Dec 31, 2024 | 61,741.99 |
| Sep 30, 2024 | 63,225.86 |
| Jun 30, 2024 | 63,060.87 |
| Mar 31, 2024 | 64,007.26 |
| Dec 31, 2023 | 63,353.69 |
| Sep 30, 2023 | 64,336.50 |
| Mar 31, 2023 | 63,798.81 |
| Dec 31, 2022 | 63,540.63 |
| Sep 30, 2022 | 66,131.86 |
| Jun 30, 2022 | 67,649.38 |
| Mar 31, 2022 | 68,092.25 |
| Dec 31, 2021 | 68,425.24 |
| Sep 30, 2021 | 68,517.80 |
| Jun 30, 2021 | 70,166.72 |